The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme

被引:169
作者
Read, Tim R. H. [1 ]
Hocking, Jane S. [2 ]
Chen, Marcus Y. [1 ]
Donovan, Basil [3 ]
Bradshaw, Catriona S. [4 ]
Fairley, Christopher K. [1 ]
机构
[1] Univ Melbourne, Melbourne Sexual Hlth Ctr, Alfred Hosp, Dept Publ Hlth, Carlton, Vic 3053, Australia
[2] Univ Melbourne, Sch Populat Hlth, Ctr Womens Hlth Gender & Soc, Carlton, Vic 3053, Australia
[3] Univ New S Wales, Kirby Inst, Sydney Sexual Hlth Ctr, Sydney, NSW, Australia
[4] Monash Univ, Alfred Hosp, Melbourne Sexual Hlth Ctr, Dept Epidemiol & Prevent Med, Prahran, Vic, Australia
基金
英国医学研究理事会;
关键词
NATURAL-HISTORY; AUSTRALIA; INFECTION; POSITIVITY; CHLAMYDIA; SERVICE; SAMPLE; TRENDS; SEX;
D O I
10.1136/sextrans-2011-050234
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background Australia provided free quadrivalent human papillomavirus vaccines to 12-18-year-old girls and women aged <= 26 years from mid-2007 until the end of 2009. After this time, only girls aged 12-13 years had access to free vaccines. Methods Before and after the study, of the proportion of new patients attending Melbourne Sexual Health Centre from mid-2004 to mid-2011, diagnosed with genital warts (GW) by risk group. Results From July 2004 to June 2011, 52 454 new patients were seen at Melbourne Sexual Health Centre and 5021 (9.6%, 95% CI 9.3% to 9.8%) were diagnosed with GW. From July 2004 to June 2007, the proportions with GW either increased or did not change in all groups. Comparing the two 12-month periods of 2007/2008 and 2010/2011, GW declined in women under 21 years from 18.6% to 1.9% and in heterosexual men under 21 years from 22.9% to 2.9%. The ORs per year for diagnosis of GW adjusted for number of sexual partners from July 2007 until June 2011 in women and heterosexual men <21 years were 0.44 (95% CI 0.32 to 0.58) and 0.42 (95% CI 0.31 to 0.60), respectively. There was no significant change in GW in women >= 30 years (OR 0.97, 95% CI 0.84 to 1.12), heterosexual men >= 30 years (OR 0.97, 95% CI 0.89 to 1.06) or in homosexual men (OR 0.95, 95% CI 0.85 to 1.07). Conclusion The dramatic decline and near disappearance of GW in women and men under 21 years of age, 4 years after commencing this programme, suggest that the basic reproductive rate has fallen below one.
引用
收藏
页码:544 / 547
页数:4
相关论文
共 16 条
  • [1] *AUSTR GOV DEP IMM, 2011, E BUS SYST RES REQ C
  • [2] Australian Government Department of Health and Ageing, 2011, IMM AUSTR PROGR HUM
  • [3] Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study
    Brotherton, Julia M. L.
    Fridman, Masha
    May, Cathryn L.
    Chappell, Genevieve
    Saville, A. Marion
    Gertig, Dorota M.
    [J]. LANCET, 2011, 377 (9783) : 2085 - 2092
  • [4] Prevalence of genital chlamydial infection among a community sample of young international backpackers in Sydney, Australia
    Davies, S. C.
    Karagiannis, T.
    Headon, V.
    Wiig, R.
    Duffy, J.
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2011, 22 (03) : 160 - 164
  • [5] de Visser RO, 2003, AUST NZ J PUBL HEAL, V27, P146, DOI 10.1111/j.1467-842X.2003.tb00802.x
  • [6] Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data
    Donovan, Basil
    Franklin, Neil
    Guy, Rebecca
    Grulich, Andrew E.
    Regan, David G.
    Ali, Hammad
    Wand, Handan
    Fairley, Christopher K.
    [J]. LANCET INFECTIOUS DISEASES, 2011, 11 (01) : 39 - 44
  • [7] Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women
    Fairley, C. K.
    Hocking, J. S.
    Gurrin, L. C.
    Chen, M. Y.
    Donovan, B.
    Bradshaw, C. S.
    [J]. SEXUALLY TRANSMITTED INFECTIONS, 2009, 85 (07) : 499 - 502
  • [8] Natural History of Genital Warts: Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine
    Garland, Suzanne M.
    Steben, Marc
    Sings, Heather L.
    James, Margaret
    Lu, Shuang
    Railkar, Radha
    Barr, Eliav
    Haupt, Richard M.
    Joura, Elmar A.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (06) : 805 - 814
  • [9] Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia
    Gertig, Dorota M.
    Brotherton, Julia M. L.
    Saville, Marion
    [J]. SEXUAL HEALTH, 2011, 8 (02) : 171 - 178
  • [10] Cancers attributable to human papillomavirus infection
    Grulich, Andrew E.
    Jin, Fengyi
    Conway, E. Lynne
    Stein, Alicia N.
    Hocking, Jane
    [J]. SEXUAL HEALTH, 2010, 7 (03) : 244 - 252